%Responders to IXEKIZUMAB in the cohort (WORLD):
by Thymidine Incorporation (95% CI): %22.3005 (18.5446,26.2911)
by IL-2 ELISpot (95% CI): %12.9108 (9.8592,16.1972)
by Combined Thymidine Incorporation & IL-2 ELISpot (95% CI): %12.9108 (9.8592,16.1972)
--
%Similarity between Thymidine Incorporation & IL-2 ELISpot predictions (95% CI): %90.4789 (88.0344,92.9233)
